Text Only

References and Notes

1) Judith Jones Putnam and Jane E Allshouse. Food Consumption, Prices, and Expenditures. Annual Data published by the United States Department of Agriculture, 1996.

2) National Fluid Milk Processor Promotion Board. Milk: What a Surprise!, 1995.

3) National Fluid Milk Processor Promotion Board, Real Men Drink Milk, 1996.

4) EMAIL letter from Dr. Susan Barr to Robert Cohen, December 19, 1996.

5) Estelle Mongeau. NIN (National Institute of Nutrition) Review, #24. Summer, 1995.

6) EMAIL letter from Dr. Suzanne Oparil to Robert Cohen, December 12, 1996.

7) National Fluid Milk Processor Promotion Board. Milk: What a Surprise!, 1995.

8) Judith Jones Putnam and Jane E. Allshouse. Food Consumption, Prices, and Expenditures. Annual Data published by the United States Department of Agriculture, 1996.

9) Vernon Heaton. The Mayflower. New York: Mayflower Books, 1980, p. 72.

10) Pictorial History of American History, vol. 1. Chicago: Davco Publishing, 1962, p.45.

11) Bradford's History of Plymouth Plantation. New York: Charles Scribner's Sons, Inc., 1908, p. 166.

12) Will Durant and Ariel Durant. The Story of Civilization, Part IV: The Age of Faith. New York: Simon and Schuster, 1950, p. 645.

13) The 1997 World Almanac and Book of Facts. K-III Reference Corporation, p. 610.

14) The World Book Encyclopedia. 1995 edition, "Milk."

15) Samuel Eliot Morison. Old Colony of New Plymouth. Alfred A. Knopf, 1956, p. 47.

16) William Bradford. Of Plymouth Plantation. NewYork: Random House, 1952, p. 49.

17) Ibid., pP. 50-51.

18) Jane Heimlich Column. Health and Healing Newsletter. Published by Julian Whitaker, July, 1994, p. 3.

19) Jane, Heimlich. What Your Doctor Won't Tell You. New York: Harper Collins, 1990.

20) Letter from Robert Cohen to Dr. Robert Collier, August 25, 1994.

21) Judith C. Juskevich and C. Greg Guyer. "Bovine Growth Hormone: Human Food Safety Evaluation." Science, vol. 249. August 24, 1990, pp. 875-884.

22) Background information on the American Association for the Advancement of Science, FAXED to Robert Cohen on June 12, 1995.

23) Ann Gibbons letter. Science, vol. 249. August 24, 1990, p. 852.

24) Monsanto's INAD application to FDA. Figure 1, p. 114.

25) Bernard Violand. "Isolation of Escherichia Coli synthesized recombinant eukaryotic proteins that contain epsilon-N-acetyllysine." Journal of Protein Science, July, 1994, pp. 1089-1097.

26) Letter from Richard Teske to Robert Cohen, August 10, 1995.

27) Kurt A. Oster, M.D. and Donald J. Ross, Ph. D. The X-O Factor. New York: Park City Press, 1983.

28) P.V. Malvern. "Prolactin and other protein hormones in milk." J. Dairy Science 45. 1977, pp. 609-616. In Reality it is:

29) P.V. Malvern, H.H. Head, R.J. Collier, F.C. Buonomo. "Periparturient Changes in secretion and mammary uptake of insulin and in concentrations of insulin and insulin-like growth factors in milk of dairy cows." J. Dairy Science 70. 1987, pp. 2254-2265.

30) B.G. Hammond, R.J. Collier, et al. "Food safety and pharmakinetic studies which support a zero (0) meat and milk withdrawal time for use of sometribove in dairy cows." Originally presented at a conference of Pharmakinetics of Veterinary Drugs, October 11-12, 1989, Fougeres, France.

31) D. Richard, G. Odaglia, P. Deslex, unpublished report. Department of Product Safety Assessment, Searle Research and Development, prepared for Monsanto Co., St. Louis, MO., 1989.

32) Jerome A. Moore, et al. "Equivalent Potency and Pharmacokinetics of Recombinant Human Growth Hormones with or without an N-Terminal Methionine." Endocrinology 122. 1988, pp. 2920.

33) Telephone call from Robert Cohen to Judy Jeskevich, September 15, 1994.

34) Genetics class taught by Professor William Burke. Southampton College, Long Island University, 1970.

35) D.E. Bauman, B.W. McBride, J.L.Burton, K. Sejrsen. Somatotropin (BST): International Dairy Federation Technical Report. Bulletin of the IDF. 293:2, February, 1994.

36) "Effect of heat treatment, enzymatic, and microbial processing and quantification of peptide hormones in milk and dairy products." Proceedings of the NIH Technology Assessment Conference: Bovine Somatotropin. December 5- 7, 1990. National Institutes of Health, Bethesda, Maryland.

37) Telephone conversations between Robert Cohen and Paul Groenewegen, April 28, 1995.

38) Paul P. Groenewegen, Brian W. McBride, John H. Burton, Theodore H. Elsasser. "Bioactivity of Milk from bST-Treated Cows." J. Nutrition 120, 1990, pp. 514-519.

39) Anthony F. Philipps, et al."Fate of Insulin-Like Growth Factors I and II Administered Orogastrically to suckling rats." Pediatric Research, vol. 37, no. 5, 1995, pp. 586-592.

40) Frystyk K, et al. "Free Insulin-like growth factors (IGF-I and IGF-II) in human serum." FEBS-lett., July 11, 1994, 348 (2), pp. 185-191.

41) Portions of the insert warning label on Monsanto's rbST product sold under the trade name of Posilac.

42) D.E. Bauman et al., in Proceedings of the 7th International Conference on Production Disease in Farm Animals, F.A. Kallfelz, Ed. (Cornell Univ., Ithaca, NY, 1989), pp. 306-323.

43) FDA's Center for Veterinary Medicine has approved the use for human consumption of milk from investigational herds treated with rbGH, based on its conclusion about the safety of the drug. The Center has not yet taken final action on the pending new animal drug applications for use of rbGH in dairy cows.

44) Code of Federal Regulations, Title 21, Part 514, revised as of 1 April 1989.

45) Food and Drug Administration, Fed. Regist., 52FR49583 (1986).

46) Code of Federal Regulations, Title 21, Part 58, revised as of 1 April 1989.

47) D.M. Matthews, Physiol. Rev. 55, 537 (1975).

48) A.S. McNeish, Ann. Allergy 53, 643 (1984); E. Lebenthal, P.C. Lee, L.A. Heitlinger, J. Pediatr. 102, 1 (1983); E. Lebenthal and Y.K. Leung, Pediatr. Ann. 16, 211 (1987).

49) I.G. Morris, in Handbook of Physiology, sect. 6, Alimentary Canal; vol. 5, Bile; Digestion; Ruminal Physiology; C.F. Code, Ed. (American Physiology Society, Washington, DC, 1968), pp. 1491-1512.

50) A.L. Warshaw, W.A. Walker, R. Cornell, K.J. Isselbacher, Lab. Invest. 25, 675 (1971); W.A. Walker, R. Cornell, L.M. Davenport, K.J. Isselbacher, J. Cell Biol. 54, 195 (1972).

51) A.L. Warshaw, W.A. Walker, K.J. Isselbacher, Gastroenterology 66, 987 (1974).

52) R.J. Levinsky, Proc. Nutr. Soc. 44, 81 (1985).

53) J.C. Leissring, J.W. Anderson, D.W. Smith, Am. J. Dis. Child. 103, 160 (1962).

54) E.J. Eastham, T. Lichauco, M.I. Grady, W. A. Walker, J. Pediatr. 93, 561 (1978).

55) D.M. Roberton, R. Paganelli, R. Dinwiddie, R.J. Levinsky, Arch. Dis. Child. 57, 369 (1982).

56) M.C. Reinhardt, Ann. Allergy 53, 597 (1984).

57) J.G. Lece, Environ. Health Perspect. 33, 57 (1979).

58) I. Jakobsson, T. Lindberg, L. Lothe, I. Axelsson, B. Benediktsson, Gut 27, 1029 (1986).

59) T. Vukavic, J. Pediatr. Gastroenterol Nutr. 2, 248 (1983).

60) ________, ibid. 3, 700 (1984).

61) A. de la Cruz et al., Fertil. Steril. 26, 894 (1975); I. Yamazaki et al., J. Takeda Res. Lab. 38, 64 (1977); J.A. Thomas and M.G. Mawhunney, in Synopsis of Endocrine Pharmacology (University Park Press, Baltimore, 1973), pp. 9-11; M. Amoss, J. Rivier, R. Guillermin, Clin. Endocrinol. Metab. 35, 175 (1972); N. Nishi, A. Arimura, D.H. Cov, J.A. Vilchez-Martinez, A.V. Schally, Proc. Soc. Exp. Biol. Med. 148, 1009 (1975).

62) W.H. Daughaday, in Endocrine Control of Growth, W.H. Daughaday, Ed. (Elsevier, Amsterdam, 1981), pp. 1-24.

63) S.L. Davis, J. Anim. Sci. 66 (suppl. 3) 84 (1988).

64) O.G.P. Isaksson, A. Lindahl, A. Nilsson, J. Isgaard, Aeta Paediatr. Scand. Suppl 343, 12 (1988).

65) S.A. Kaplan, Am. J. Dis. Child. 110, 232 (1965).

66) J.L. Kostyo, Metabolism 23, 885 (1974).

67) F. Matsuzaki and M.S. Raben, Annu. Rev. Pharmacol. 5,137 (1965); G.P. Talwar et al., in Recent Progress in Hormone Research, G. Pincus, Ed. (Academic Press, New Yrk, 1975), vol. 31, pp. 141-174; O.G. P. Isakson , S. Eden, J.O. Jansson, Annu. Rev. Physiol. 47, 483 (1985); R.D. Boyd and D.E. Bauman in Annual Growth Regulation, D.R. Campion, G. J. Hausman, R.J. Martin, Eds. (Plenum, New York, 1989), pp. 257- 293.

68) H. Green, M. Morikawa, T. Nixon, Differentiation 29, 195 (1985).

69) E. Knobil and R.O. Greep, in Recent Progress in Hormone Research, G. Pancus, Ed. (Academic Press, New York, 1959), vol. XV, pp. 1-69.

70) M.S. Raben, ibid., pp. 71-114.

71) N. Yamasaki, M. Kikutani, M. Sonenberg, Biochemistry 9, 1107 (1970).

72) D.M. Bergenstal and M.B. Lipsett, J. Clin. Endocrinal Metab. 20, 1427 (1960).

73) J.B. Mills, S.C. Howard, S, Scapa, A.E. Wilhelmi, J. Biol. Chem. 245, 3407 (1970).

74) C.A. Baile and D.H. Krestel-Rickert, Feed Manage, 36, 26 (1985).

75) W.V. Moore, S. Draper, C.H. Hung, Horm. Res. 21, 33 (1985).

76) M. Sonenberg et al., in Growth and Growth Hormone, A. Pecile and E.F. Muller, Eds. (Excerpta Medica, Amsterdam, 1972), pp. 75-90.

77) L. Graf and C.H. Li, Biochemistry 13, 5408 (1974).

78) K. Hara, C.J.H. Chen, M. Sonenberg, ibid. 17, 550 (1978).

79) M. Sonenberg, M. Kikutani, C.A. Free, A.C. Nadler, J.M. Dellacha, Ann. N.Y. Acad. Sci. 148, 532 (1968).

80) A.C. Nadler, M. Sonenberg, M.I. New, C.A. Free, Metabolism 16, 830 1967); M. Sonenberg et al., ibid. 14, 1189 (1965).

81) J.L. Nappier and G.A. Hoffman, unpublished report (Agricultural Research and Development Laboratories, Union Co., Kalamazoo, MI, 1986); W.J. Seaman and P.J. Skinner, unpublished report (Pharmaceutical Research and Development, Upjohn Co., Kalamazoo, MI, 1986).

82) D.G. Serota, N.G. Phipps, R.D. Alsaker, J.F. Carter, B. Colpean, unpublished report (Hazelton Laboratories America, Inc., prepared for Monsanto Co., St. Louis, MO, 1984).

83) D. Richard, G. Odaglia, P. Deslex, unpublished report (Department of Product Safety Assessment, Searle Research and Development, prepared for Monsanto Co., St. Louis, MO 1989).

84) J.E. Fischer, R.L. Depew, C.A. Lowe, J. Panfili, unpublished report (Agricultural Research Division, American Cynanamid Co., Wayne, NJ, 1984).

85) L.F. Fisher, unpublished report (Toxicology Division, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN, 1985).

86) Note: Organs weighed included, at a minimum, the following: adrenals, brain, heart, kidneys, liver, ovary, spleen, and testes. Histopathological examination included, at a minimum, the following organs: adrenals, bone, bone marrow, brain, colon, duodenum, esophagus, heart, ileum, jejunum, kidneys, liver, lung, lymph nodes, mammary gland, ovary, pancreas, parathyroid, prostate, salivary gland, skeletal muscle, skin, spinal cord, spleen, stomach, testes, thymus, thyroid, trachea, urinary bladder, uterus, and all gross lesions.

87) B.K. Birmingham et al., J. Dairy Sci. 71, 227 (1988).

88) J.A. Moore et al., Endocrinology 122, 2920 (1988).

89) K.L. Simkins, in Proceedings of the California Animal Nutrition Conference on Nutrient Partitioning, E. Robb, Ed. (Fresno, California, 1987), pp. 36-45.

90) P.P. Groenewegen, B.W. McBride, J.H. Burton, T.H. Elasser, J. Nutr. 120, 514 (1990).

91) G. Van den Berg, in Use of Somatotropin in Livestock Production, K. Sejrsen, M. Vestergaard, A. Neimann-Sorensen, Eds. (Elsevier, Science, New York, 1989), pp. 178-191; R.J. Baer et al., J. Dairy Sci. 72, 1424 (1989).

92) A.J. D'Ercole, L.E. Underwood, J.J. Van Wyk, J. Pediatr. 90, 375 (1977); R.W. Furlanetto, L.E. Underwood, J.J. Van Wyk, A.J. D'Ercole, J. Clin. Invest. 60, 648 (1977).

93) J.F. Perdue, Can. J. Biochem. Cell Biol. 62, 1237 (1984).

94) D. Matier, L.E. Underwood, M. Maes, M.L. Davenport, J.M. Ketelslegers, Endocrinology 123, 1053 (1988); K.C. Copeland, L.E. Underwood, J.J. Van Wyk, J. Clin. Endocrinol. Metab. 50, 690 (1980); M.B. Grant et al., ibid. 63, 981 (1986).

95) J.J. Van Wyk, M.E. Svoboda, L.E. Underwood, J. Clin. Endocrinol. Metab. 50, 206 (1980).

96) J. Zapf and E.R. Froesch, Horm. Res. 24, 121 (1986).

97) K. Hall and V.R. Sara, in Vitamins and Hormones (Academic Press, New York, 1983), vol. 40, pp. 175-233; L.E. Underwood, A.J. D'Ercole, D.R. Clemmons, J.J. Van Wyk, Clin. Endocrinol. Metab. 15, 59 (1986); R.C. Baxter, Adv. Clin. Chem. 25, 49 (1986).

98) A.J. D'Ercole, A.D. Stiles, L.E. Underwood, Proc. Natl. Acad. Sci. U.S.A. 81, 935 (1984).

99) C.C. Orlowski and S.D. Chernausek, Endocrinology 123, 44 (1988); J. Isgaard et al., ibid. 122, 1515 (1988); J. Isgaard, A. Nilsson, K. Vikman, O.G.P. Isaksson, J. Endocrinol. 120, 107 (1988); N.L. Schlechter, S.M. Russell, E.M. Spencer, C.S. Nicoll, Proc. Natl. Acad. Sci. U.S.A. 83, 7932 (1986).

100) J. Zapf, C. Hauri, M. Waldvogel, E.R. Froesch, J. Clin. Invest. 77, 1768 (1986).

101) A. Skottner, R.G. Clark, I.C.A.F. Robinson, L. Fryklund, J. Endocrinol. 112, 123 (1987).

102) E. Schoenle, J. Zapf, C. Hauri, T. Steiner, E.R. Froesch, Acta Endocrinol. 112, 123 (1987).

103) K. Hall and V.R. Sara, Clin. Endocrinol. Metab. 13, 91 (1984).

104) R.C. Baxter, Z. Zaltsman, J.R. Turtle, J. Clin. Endocrinol. Metab. 58, 955 (1984).

105) A.N. Corps, K.D. Brown, L.H. Rees, J. Carr, C.G. Prosser, ibid. 67, 25 (1988).

106) A. Honegger and R.E. Humbel, J. Biol. Chem. 261, 569 (1986).

107) L.F. Fisher and E.L. Russell, unpublished report (Toxicology Division, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN, 1989).

108) J.B. Terrill, unpublished report (Hazelton Laboratories of America, Inc., prepared for Monsanto Agricultural Co., St. Louis, MO 1989).

109) T.C. White et al., unpublished report MSL 8671 (Monsanto Agricultural Co., St. Louis, MO, 1989).

110) R.J. Collier et al., unpublished report MSL 8531 (Monsanto Agricultural Co., St. Louis, MO, 1988).

111) D. Schams and H. Karg, unpublished Elanco report, Eli Lilly & Co., dated 23 September 1988 (Institute of Physiology, Technische Universitat Munchen, D- 8050 Freising-Weihenstephan, FRG, 1988); unpublished Elanco report, Eli Lilly & Co. (Insitute of Physiology, Technische Universitat Munchen, D-8050 Freising- Weihenstephan, FRG, 1988).

112) S.R. Davis, P.D. Gluckman, A.M. Bryant, unpublished Elanco report, Eli Lilly & Co. (Ruakura Agricultural Centre, Hamilton, New Zealand, 1989).

113) T.C. White et al., unpublished report MSL 8633 (Monsanto Agricultural Co., St. Louis, MO, 1989).

114) M.A. Miller et al., unpublished report MSL 8673 (Monsanto Agricultural Co., St. Louis, MO, 1989).

115) M.A. Miller, T.C. White, R.J. Collier, unpublished report (Monsanto Agricultural Co., St. Louis, MO, 1989).

116) We thank S. Sechen for her contributions to the manuscript.

117) D. Richard, G. Odaglia, P. Deslex. Unpublished report, Department of Product

Safety Assessment, Searle Research and Development, prepared for Monsanto

Monsanto Co., St. Louis, MO., 1989.

118) Letter from Dr. Richard Teske to Robert Cohen, August 10, 1995.

119) Reference #45 of the Juskevich and Guyer paper. (See 45* in the list of references contained in chapter 3).

120) Telephone call from Robert Cohen to Robert Collier, Ph.D., September 15, 1994.

121) Freedom of Information Act Request, reference # 94-39274.

122) Science News, vol. 138, August 25, 1990, p. 116.

123) Barbano, Lynch, Bauman, Hartnell. "Influence of sometribove (recombinant methionyl bovine somatotropin) on general milk composition." J. Dairy Science, 71 Suppl 1:101, 1988.

124) Daughaday & Barbano. "Bovine Somatotropin supplementation of dairy cows, Is the Milk Safe?" JAMA, 264(8), August 22, 1990, pp. 1003-1005.

125) Monsanto Press Release, June, 1992.

126) Shari Roan. "Despite Bad Report, Milk Still Does a Body Good." Los Angeles Times, November 18, 1992, pp. E-1.

127) Ronald E. Kleinman, et al. "The Use of Whole Cow's Milk in Infancy." Pediatrics, vol. 89, no. 6, June, 1992, pp. 1105-1109.

128) Dr. Neal Barnard. "Doctors File Complaint With FTC Over 'Milk Mustache' Ads." Physicians Committee for Responsible Medicine News Release, April, 1995.

129) Harvey and Marilyn Diamond. Fit For Life. Warner Communications, 1994.

130) Devra Lee Davis. "Decreasing cardiovascular disease and increasing cancer among whites in the United Staes from 1973 through 1987." JAMA, vol. 271, no. 6, September 9, 1994, pp. 431-437.

131) Reference #42 of the Juskevich and Guyer paper. (See 42* in the list of references contained in chapter 3).

132) Executive Branch Report on BST issues. Issued February 9, 1994.

133) Neal Barnard. "Good Medicine," Physician's Committee for Responsible Medicine, vol. 2, no. 4, Autumn, 1993.

134) Letter from Ann Beagley of Freedom of Information Clearinghouse to Robert Cohen, July 11, 1995.

135) James Bovard. "First Step to an FDA Cure: Dump Kessler." Wall Street Journal, vol. CCXXIV, no. 112, December 8, 1994, p. A18.

136) "Mother Nature is Lucky Her Products Don't Need Labels" (advertisement). National Geographic, vol. 158, no. 3, September, 1980, p. 433.

137) http://www.monsanto.com/MonPub/Environment/MonsantoPledge.

138) McDermott. Journal of The American Veterinary Association, May 15, 1994.

139) The Fifth Estate, September 9, 1994. Broadcast on Canadian Television.

140) The Congressional Record, vol. 131, no. 58, May 7, 1985.

141) Michael R. Taylor. "The De Minimus Interpretation of the Delaney Clause: Legal and Policy Rationale." Journal of the American College of Toxicology, vol. 7, no. 7, Nov. 4, 1988.

142) James Ridgeway. "Robocow: How Tomorrow's Farming is Poisoning Today's Milk." The Village Voice, March 14, 1995.

143) Margaret Miller's Application for Federal Employment, Form SF 171.

144) Robert Collier, Margaret Miller, et al. "Nutrient balance and stage of lactation effect response of Insulin, Insulin-like growth factor I and II and the insulin-like binding proteins 2 to somatotropin administration in dairy cows." American Institute of Nutrition, December, 1990.

145) Dale Bauman, Margaret Miller, et al. "Response of Somatomedins (IGF-I and IGF-II) in Lactating Cows to Variations in Dietary Energy and Protein and Treatment with Recombinant n-Methionyl Bovine Somatotropin." Journal of Animal Science.

146) Linda Grasse, ed. FDA Veterinarian, May/June, 1994.

147) Statement by Stephen Sundloff to Congress, September 28, 1994.

148) Statement by Mr. Michael Taylor to Congress, September 28, 1994.

149) B.N. Violand, et al. "Isolation of Escherichia coli synthesized recombinant eukaryotic proteins that contain epsilon-N-acetyllysine." (Animal Sciences Division, Monsanto Corporation, St. Louis, Missouri.) Protein Sci., 1994 July 3, 1994,pp.1089-1097.

150) J.C. Juskevich; C.G. Guyer. "Bovine growth hormone: Human Food Safety Evaluation." Science, volume 249, August 24, 1990, pp. 875-884.

151) C.E. Rogler, et al. "Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice." Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York. J Biol Chem, May 13, 1994, p. 269.

152) B.G. Hammond, et al. "Food safety and pharmacokinetic studies which support a zero (0) meat and milk withdrawal time for use of sometribove in dairy cows." Monsanto Agricultural Company, Animal Sciences Division, St. Louis, Missouri. Pharmacokinetics of Veterinary Drugs, October 11-12, 1989.

153) D. Kleinman, et al. "Regulation of endometrial cancer cell growth by insulin- like growth factors and the luteinizing hormone-releasing hormone antagonist SB- 75." Clinical Biochemistry Department, Faculty of Health Sciences, Ben-Gurion University of the Negev, Sokora Medical Center of Kupat Holim, Beer-Sheva, Israel. Regul-Pept., October 20, 1993, 48(1-2), pp. 91-98.

154) A. D'Errico, et al. "Expression of insulin-like growth factor II (IGF-II) in human hepatocellular arcinomas: An immunohistochemical study." Institute of Pathological Anatomy, University of Bologna, Italy. Pathol-Int., February, 1994, 44(2), pp. 131-137.

155) C.F. Kwok, et al. "Insulin-like growth factor-I receptor increases in aortic endothelial cells from diabetic rats." Department of Medicine, Veterans General Hospital-Taipei, Republic of China. Metabolism, November, 1993, 42(11), pp. 1381-1385.

156) J. Wimalasena, et al. "Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors." Department of Obstetrics/Gynecology, Graduate School of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee. Oncol-Res., 1993, 5(8), pp. 325-337.

157) D.D. DeLeon, et al. "Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells." Department of Pediatric Endocrinology, Stanford University Medical School, California. Growth Factors, 1992, 6(4), pp. 327-336.

158) D.M. Martin, et al. "IGF receptor function and regulation in autocrine human neuroblastoma cell growth." Department of Neurology, University of Michigan, Ann Arbor. Regul. Pept., October 20, 1993, 48(1-2), pp. 225-232.

159) D. Ambrose, et al. "Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-I and its receptor." Department of Pathology, Jefferson Medical College, Philadelphia, Pennsylvania. J-Cell-Physiol., April, 1994 159(1), pp. 92-100.

160) F.C. Nielsen, et al. "Insulin-like growth factor IImRNA, peptides, and receptors in a thoracopulmonary malignant small round cell tumor. Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark. Cancer, February 15, 1994, 73(4), pp.1312-1319.

161) D. Prager, et al. "Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant." Department of Medicine, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine, Los Angeles, California. Proc-Natl-Acad-Sci-USA, March 15, 1994, 91(6), pp. 2181-2185.

162) K. Raile, et al. "Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor." Department of Pediatric Endocrinology, Children's Hospital, University of Munich, Germany. J-Cell Physiol., June, 1994, 159(3), pp. 531-541.

163) K.S. Langford, et al. "The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation." Academic Department of Medicine, King's College School of Medicine and Dentistry, London, UK. Eur-J- Clin-invest., September, 1993, 23(9), pp. 503-516.

164) H. Olanrewaju, et al. "Trophic action of local intraileal infusion of insulin-like growth factor-I: polyamine dependence." Am-J-Physiol., 263:E282-286, 1992.

165) Baumrucker, C.R., et al. "Effects of dietary recombinant human insulin-like growth factor-I on concentrations of hormones and growth factors in the blood of newborn calves." Department of Dairy and Animal Science, Pennsylvania State University, University Park, Pennsylvania. J-Endrocrinol., January, 1994, 140(1), pp. 15-21.

166) R.G. Taylor, et al. "Hormonal regulation of intestinal adaptation." Department of Surgery, Royal Children's Hospital, Parkville, Victoria, Australia. Baillieres-Clin-Endocrinol-Metab., January, 1994, 8(1), pp.165-183.

167) R.J. Playford, et al. "Effect of Luminal growth factor preservation on intestinal growth." The Lancet, 1993, 2, pp. 843-848.

168) R.K. Rae, et al. "Presence of multiple forms of peptidase inhibitors in rat milk." Department of Pharmacology, Steele Memorial Children's Research Center, University of Arizona, Tucson. J-Pediatr-Gastroenterol-Nutr., November 17, 1993, (4), pp.414-420.

169) K.A. Oster, et al. "Liposomes as a proposed vehicle for the persorption of bovine xanthine oxidase." Proc. Soc. Exper. Bio. & Med., January, 1980, 163(1).

170) J. Frystyk, et al. "Free insulin-like growth factors (IGF-I and IGF-II) in human serum." Institute of Experimental Clinical Research, Asrhus University Hospital, Denmark. FEBS-Lett., July 11, 1994, 348(2), pp. 185-191.

171) Z. Kachra, et al. "The augmentation of insulin-like growth factor-I messenger ribonucleic acid in cultured rat hepatocytes: activation of protein kinease-A and - C is necessary, but not sufficient." Polypeptide Hormone Laboratory, Royal Victoria Hospital, Montreal, Quebec, Canada. Endocrinology, February, 1994, 134(2), pp. 702-708.

172) M. Frodin, et al. "Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation." Department of Clinical Chemistry, Bispebjerg Hospital, Copenhagen, Denmark. Proc-Natl-Acad-Sci-USA, March 1, 1994, 91(5), pp. 1771-1775.

173) D. Romagnono, et al. "Lactogenic hormones and extracellular matrix regulate expression of IGF-I linked to MMTV-LTR in mammary epithelial cells." Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg, Virginia. Mol-Cell-Endocrinol., October, 1993, 96(1-2), pp. 147-157.

174) J. Gillespie, et al. "Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors." Academic Surgical Unit, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK. Br.-J-Cancer, December, 1993, 68(6), pp. 1122-1126.

175) R.P. Glick, et al. "Identification of insulin-like growth factor (IGF) and glucose transporter-I and -3 mRNA in CNS tumors." Department of Neurology, University of Illinois at Chicago, Cook County Hospital. Regul-Pept., October, 20,1993, 48(1-2), pp. 251-256.

176) F. Atiq, et al. "Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer." Labor d'Immunologie, Faculte de Medecin, Marseille, France. Int-J-Cancer, May 15, 1994, 57(4), pp. 491-497.

177) T. Yashiro, et al. "Increased activity of insulin-like growth factor-binding protein in human thyroid papillary cancer tissue." Department of Sirgery, Tsukuba University, Ibaraki, Japan. Jpn-J-Cancer-Res., January, 1994, 85(1), pp. 46-52.

178) K. Robbins, et al. "Immunological effects of insulin-like growth factor--- enhancement of immunoglobulin synthesid." Department of Immunology, Genetech, Inc., South San Francisco, California. Clin-Exp-Immunol., February, 1994, 95(2), pp. 337-342.

179) K. Yun, et al. "Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney." Department of Pathology, University of Otago Medical School, Dunedin, New Zealand. Lab-Invest., November, 1993, 69(5), pp. 603-615.

180) C.P. Minniti, et al. "Specific expression of insulin-like growth factor-II in rhabdomyosarcoma tumor cells." Institutes of Health, Bethesda, Maryland. Am-J-Clin-Pathol., February, 1994, 101(2), pp. 198-203.

181) C.C. Kappel, et al. "Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth." Molecular Oncology Section, National Cancer Institute, Bethesda, Maryland. Cancer-Res., May 15, 1994, 54(10), pp. 2803-2807.

182) M. Lippman. "Growth factors, receptors and breast cancers." (IGF-I and related growth factors are critically involved in aberrant growth of human breast cancer cells.) J. Natl. Inst. Health Res., 1991, 3, pp. 59-62.

183) A.V. Lee, et al. "Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells." Imperial Cancer Research Fund, Breast Biology Group, School of Biological Sciences, University of Surrey, Guildford, UK. Mol-Cell- Endocrinol., March, 99(2), pp. 211-220.

184) J.C. Chen, et al. "Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in human breast carcinoma cell line." Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. J-Cell-Physiol., January, 1994, 158(1), pp. 69-78.

185) J.A. Figueroa, et al. "Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I serum, and estrogen-dependent growth of MCF-7 human breast cancer cells." Department of Medicine, University of Texas Health Science Center, San Antonio, Texas. J-Cell-Physiol., November, 1993, 157(2), pp. 229- 236.

186) X.S. Li, et al. "Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in breast carcinoma cell lines." Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. Exp-Cell-Res., March, 1994, 211(1), pp. 68-73.

187) A. Krasnick, et al. "Insulin-like growth factor-I (IGF) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer." Institute of Endocrinolgy, Chaim Sheba Medical Center, Tel-Hashomer, Israel. J-Clin-Endocrinol-Metab, February, 1994, 78(2).

188) E.A. Musgrove, et al. "Acute effects of growth factors on T-47D breast cancer cell cycle progression." Cancer Biology Division, Garvan Institute for Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia. Eur-J-Cancer, 29A (16), 1993, pp. 2273-2279.

189) Gina Kolata. "New ability Find Earliest Cancers: A Mixed Blessing?" The New York Times, Science Section, November 8, 1994, p. C1.

190) Judith Blake. "Some Milk Labeling Called Improper." The Seattle Times, September, 1, 1994.

191) Bob Walter. "Biotech Milk Hormone Weathers a Challenge." The Sacramento Bee, August 30, 1994.

192) Redbook, vol. 178, January, 1992, p. 116.

193) A bibliography of BST-related issues, HHS Document # 90-13.

194) Marian Burros. "The Debate Over Milk and an Artificial Hormone." The New York Times, Section C4, May 18, 1994.

195) Ellen Ferguson. The Burlington Free Press, February 24, 1994, p. 7B.

196) Ibid.

197) Senate Bill #234, 89th General Assembly, State of Illinois (LRB8900063FNsb).

198) Vegetarian Times, February, 1994.

199) Joel McNair. "FDA: 9,500 Cows Had Problems with BGH." Agri-View, March 23, 1995, Section 2, p. 1.

200) Bob Arnot. "The Great American Milk War." Good Housekeeping, June, 1994, p. 50.

201) Keith Schneider. The New York Times, Business Section, March 9, 1994.

202) "Cash Cow." Newsweek, December 6, 1993.

203) Philip Elmer-Dewitt. "Udder Insanity." Time, May 17, 1993, p. 52.

204) Philip Elmer-Dewitt. "Brave New World of Milk." Time, February 14, 1994, p 31.

205) Staff Editorial. "The Milk Lobby." The Wall Street Journal, March 14, 1994.

206) Peter Hubber. "In Praise of the Bionic Cow." Forbes, August 6, 1990, vol. 146, p.108.

207) Science Editorial. December 14, 1990, p. 1506.

208) Sam Epstein. BST Article. The Los Angeles Times, March 20, 1994.

209) Dennis Bier's 3 page letter to David Kessler, February 25, 1994.

210) Bill Haworth. Dairy Coalition's (undated) response to Sam Epstein.

211) Sam Epstein. "Insulin-like Growth Factor 1 in Biosynthetic Milk is a Potential

Risk Factor for Breast Cancer and Gastrointestinal Cancers."A copy of which I reviewed for Dr. Epstein.

212) Michael Hansen's testimony before the joint meeting of the Food Advisory Committee and the Veterinary Medicine Advisory Committee, Consumers Union, May 6, 1993.

213) Philip Hager. "Courts Get Health Alert Authority." The Los Angeles Times, March 20, 1993, p. A3.

214) Michael Hansen's testimony before the Veterinary Advisory Committee on rbGH use, March 31, 1993.

215) "Milk Prices Raised." The Los Angeles Times, November 17, 1993.

216) Eric Millstone. "Plagiarism or Protecting Public Health." Nature, vol. 371, October 20, 1994, p. 647.

217) Alika Brandenberg. Green Grass and White Milk. New York: Crowell, 1974.

218) Rod Serling's introduction to each episode of The Twilight Zone, recorded and transcribed from a 1960 episode.

219) Michael McMenamin and Walter McNamara. Milking the Public. Chicago: Nelson-Hall, 1980.

220) D. Bauman. International Dairy Federation Bulletin, December, 1993.

221) Ibid.

222) "Which Milk to Choose?" Consumers Union, September, 1991, vol. 56, p. 627.

223) James Payne. "The Culture of Spending: Why Congress Lives Beyond Our Means." National Review, April 27, 1992.

224) "The use of whole cow's milk in infancy." Pediatrics, American Academy of Pediatrics, Committee on Nutrition, 1992, 89, pp. 1105-1109.

225) J.A.T Pennington and H.N Church. "Food values of portions commonly used." New York: Harper and Row, 1989.

226) E.E. Ziegler, S.J. Fomon, S.E. Nelson, et al. "Cow milk feeding in infancy: further observations on blood loss from the gastrointestinal tract." J Pediat., 1990, 116, pp. 11-18.

227) F.W. Scott. "Cow milk and insulin-dependent diabetes mellitus: is there a relationship?" Am J Clin Nutr, 1990, 51, pp. 489-491.

228) J. Karjalainen, J.M. Martin, M. Knip, et al. "A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus." N Engl J Med. 1992, 327, pp. 302-307.

229) D.M. Robertson, R. Paganelli, R. Dinwiddie, R.J. Levinsky. "Milk antigen absorption in the preterm and term neonate." Arch Dis Child, 1982, 57, pp. 369-372.

230) G.J. Bruining, J. Molenaar, C.W. Tuk, J. Lindeman, H.A. Bruining, B. Marner. "Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes." Diabetologia, 1984, 26, pp. 24-29.

231) D.W. Cramer, et al. "Galactose consumption and metabolism in relation to the risk of ovarian cancer." The Lancet, 1989, 2, pp. 66-71.

232) F.J. Simoons. "A geographic approach to senile cataracts: possible links with milk consumption, lactase activity, and galatose metabolism." Digestive Diseases and Sciences, 1982, 27, pp. 257-264.

233) C. Couet, P. Jan, G. Debry. "Lactose and cataract in humans: a review." J Am Coll Nutr, 1991, 10, pp. 79-86.

234) M.F. Holick, Q. Shao, W.W. Liu, T.C. Chen. "The vitamin D content of fortified milk and infant formula." New Engl J Med., 1992, 326, pp. 1178-1181.

235) C.H. Jacobus, M.F. Holick, Q. Shao, et al. "Hypervitaminosis D associated with drinking milk." New Engl J Med., 1992, 326, pp.1173-1177.

236) B.L. Riggs, H.W. Wahner, J. Melton, L.S. Richelson, H.L. Judd, M. O'Fallon. "Dietary calcium intake and rates on bone loss in women.' J Clin Invest., 1987, 80, pp. 979-982.

237) B. Dawson-Hughes "Calcium supplementation and bone loss: a review of controlled clinical trials." Am J Clin Nutr., 1991, 54, pp. 274S-280S.

238) B. Dawson-Hughes, P. Jacques, C. Shipp. "Dietary calcium intake and bone loss from the spine in healthy postmenopausal women." Am J Clin Nutr., 1987, 46, pp. 685-687.

239) R.B. Mazess, H.S. Barden. "Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills." Am J Clin Nutr., 1991, 53, pp. 132-142.

240) G. Kolata. "How important is dietary calcium in preventing osteoporosis?" Science, 1986, 233, pp. 519-520.

241) R.P. Heaney, C.M. Weaver. "Calcium absorption from kale." Am J Clin Nutr., 1990, 51, pp. 656-657.

242) M.J. Nicar, C.Y.C. Pak. "Calcium bioavailability from calcium carbonate and calcium citrate." J Clin Endocrinol Metab., 1985, 61, pp. 391-393.

243) M.E. Nelson, E.C. Fisher, F.A. Dilmanian, G.E. Dallal, W.J. Evans. "A 1-y walking program and increased dietary calcium in postmenopausal women: effect on bone." Am J Clin Nutr., 1991, 53, pp. 1304-1311.

244) F.H. Nielsen, C.D. Hunt, et al. "Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women." FASEB, 1987, 1, pp. 394-97.

245) M.B. Zemel. "Role of the sulfur-containing amino acids in protein-induced hypercalciuria in men." J Nut., 1981,111, p. 545.

246) M. Hegsted, et al. "Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake." J Nutr., 1981, 111, p. 553.

247) A.G. Marsh, T.V. Sanchez, O. Mickelsen, J. Keiser, G. Mayor. "Cortical bone density of adult lacto-ovo-vegetarian and omnivorous women." J Am Dietetic Asso., 1980, 76, pp. 148-151.

248) Handbook of the Nutritional Contents of Foods. USDA, New York: Dover Publications, 1995, p. 38.

249) Barbara Kraus. The Dictionary of Sodium, Fats and Cholesterol. New York: Grosset & Dunlap, 1974, p. 212.

250) Freedom of Information Adverse Reaction Report of humans, accidentally (and intentionally) injected with rbGH (Posilac), January 14, 1995.

251) Scott Veggeberg. "Beyond Steroids." New Scientist, vol. 14, no. 2012, January 13, 1996.

252) Ibid.

253) Barbara Kraus. The Dictionary of Sodium, Fats and Cholesterol. New York: Grosset & Dunlap, 1974, p. 212.

254) H.D. Belitz, W. Grosch. Food Chemistry. Translated from 2nd. German Edition by D. Hadziyev, Pub. Springer-Verlag, Berlin, 1987, p. 379.

255) Clark E. Grosvenor, et. al. "Hormones and Growth Factors in Milk." Endocrine Reviews, vol. 14, no. 6, 1992.

256) Ratsimamanga, et al. C.R. Soc. Biol (France) 150, pp. 2179-2182.

257) Klagsburn, M. "Human milk stimulates DNA synthesis and cellular proliferation in cultured fibriblasts." Proceeds of Natl. Acad. Sci. 1978, 75, pp. 5057-61.

258) Kurt A. Oster, M.D., and Donald J. Ross, Ph. D. The X-O Factor. New York: Park City Press, 1983

259) Cancer Facts & Figures - 1994. American Cancer Society, Atlanta, Georgia, (Inside cover-Incidence).

260) Cancer Treatment Centers Brochure, 1-800-FOR-HELP (367-4357).

261) Carlos Arteaga. "Interference of the IGF system as a strategy to inhibit breast cancer growth." Breast Cancer Research and Treatment, 1992, 22, pp. 101-106.

262) Andreas Friedl, et al. "Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy." European Journal of Cancer, 1993, 29A (10), pp. 1368-1372.

263) J. Gillespie, et al. "Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors." Br.-J-Cancer, December, 1993, 68(6), pp. 1122-1126.

264) R.P. Glick, et al. "Identification of insulin-like growth factor (IGF) and glucose transporter-I and -3 mRNA in CNS tumors." Regul-Pept., October 20, 1993, 48(1-2), pp. 251-256.

265) F. Atiq, et al. "Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer." Int-J-Cancer, May 15, 1994, 57(4), pp. 491-497.

266) T. Yashiro, et al. "Increased activity of insulin-like growth factor-binding protein in human thyroid papillary cancer tissue." Jpn-J-Cancer-Res., January, 1994, 85(1), pp. 46-52.

267) K. Robbins, et al. "Immunological effects of insulin-like growth factor--- enhancement of immunoglobulin synthesid." Clin-Exp-Immunol., February, 1994, 95(2), pp. 337-342.

268) Yun, K, et al. "Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney." Lab-Invest., November, 1993, 69(5) pp. 603-615.

269) C.C. Kappel, et al. "Human osteosarcoma cell lines are dependent on insulin-like growth factor I forin vitro growth." Cancer-Res., May 15, 1994, 54(10), pp. 2803-2807.

270) M. Lippman. "Growth factors, receptors and breast cancers." J. Natl. Inst. Health, Res. 3, 1991, pp. 59-62.

271) A.V. Lee, et al. "Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells." Mol-Cell-Endocrinol., March, 99(2), pp. 211-220.

272) J.C. Chen, et al. "Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in human breast carcinoma cell line." J-Cell-Physiol., January, 1994, 158(1), pp. 69-78.

273) J.A. Figueroa, et al. "Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I serum, and estrogen-dependent growth of MCF-7 human breast cancer cells." J-Cell-Physiol., November, 1993, 157(2), pp. 229-236.

274) X.S. Li, et al. "Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in breast carcinoma cell lines." Exp-Cell-Res., March, 1994, 211(1), pp. 68-73.

275) A. Krasnick, et al. "Insulin-like growth factor-I (IGF) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer." J-Clin-Endocrinol- Metab., February, 1994, 78(2).

276) E.A. Musgrove, et al. "Acute effects of growth factors on T-47D breast cancer cell cycle progression." Eur-J-Cancer, 1993, 29A (16), pp. 2273-2279.

277) Gina Kolata. "New ability Find Earliest Cancers: A Mixed Blessing?" The New York Times, Science Section, November 8, 1994, p. C1.

278) Cure 2000, Leukemia Society Update, March, 1994.

279) Letter from Shaw Watanabe (Epidemiology Division of the Japan Leukemia Study Group) to The Lancet, February, 1988.

280) Growth Hormone Treatment and Leukemia. Press Release of the Lawson Wilkins Pediatric Endocrine Society, May 6, 1968.

281) R. Weiss. Science News, May 18, 1988, vol. 133, p. 308.

282) J.A. Moore, et al. Endocrinology, 1988, 122, p. 2920.

283) John E. Priestly, M.D., with Janet Barton. The Allergy Discovery Diet. New York: Doubleday, 1990, p. 29.

284) Harvey and Marilyn Diamond. Fit For Life. New York: Warner Books, 1985, pp. 80-87.

285) Myron Lipowitz, M.D., Tova Navarra, RN. Allergies: A-Z. New York: Facts on File, 1994, p. 174.

286) Julie Klotter. Townsend Medical Newsletter, May, 1995.

287) Nathaniel Mead. "Don't Drink Your Milk." Natural Health, July/August, 1994, p. 70.

288) W.E. Parish et al. "Hypersensitivity to Milk and Sudden Death in Infancy." The Lancet, vol. 2, 7160, November 19, 1960, pp. 1106-1110.

289) "Cow Milk Allergies and Sudden Infant Death." The Lancet, vol. 344, November 5, 1994,

290) W.J. Howatt, et al. "Pulmonary Immunopathology of Sudden Infant Death Syndrome." The Lancet, vol. 343, June 4, 1994, pp. 1390-1392.

291) Facts About SIDS, Sudden Infant Death Syndrome 1-800-221-7437, SIDS ALLIANCE, Baltimore, Maryland.

292) Cavagni, et al. "Allergy to cow's milk proteins in childhood: The author's personal experience and new diagnostic and therapeutic proposals." Pediatr- Med-Chir., September/October, 1994, 16(5), pp. 413-419.

293) Iacono, et al. "Chronic Constipation as a Symptom of Cow Milk Allergy." J. Pediatr., January, 1995, 126(1), pp. 34-39.

294) Kaila, et al. "A Prospective Study of Humoral Immune Response to Cow Milk Antigens in the First Year of Life." Pediatr-Allergy-Immunol., August, 1994, 5(3) pp. 164-169.

295) Host. "Cow's Milk Protein Allergy and Intolerance in Infancy. Some Clinical, Epidemiological and immunological aspects." Pediatr.-Allergy-Immunol., 1994, 5(5 Suppl), pp. 1-36.

296) "What You Need To Know About Diabetes." The American Diabetes Association, 1994.

297) Rao, et al. "SC-18862 (ASPARTAME) 52 Week Oral Toxicity Study in the Infant Monkey," pp. 3179-3218 of an application made by Searle Pharmaceutical to FDA for Aspartame approval.

298) "More Evidence that Milk Causes Diabetes and Anemia," Prevention and Nutrition, Autumn, 1992, p. 13.

299) Karjalainen. "A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus." N Engl J Med., 1992, 327, pp. 302-307.

300) "Cow's Milk: Environmental Factor in IDDM (Insulin Dependent Diabetes Mellitus)." Journal of the American Diabetic Association. vol. 16, December, 1993.

301) Verge, et al. "Environmental Factors in Childhood IDDM, A Population-Based Case-Control Study." Diabetes Care. December, 1994, 17(12), pp. 1381-1389.

302) Virtanen and Aro. "Dietary factors in the aetiology of diabetes." Ann-Med. Dec., 1994, 26(6), pp. 469-478.

303) Fava, et al. "Relationship between dairy product consumption and the incidence of IDDM in childhood in Italy." Diabetes Care, December, 1994, 17(12), pp. 1488-1490.

304) Norris and Pietropaolo. "A bovin albumin peptide as a possible trigger of insulin-dependent diabetes mellitus." J. Endocrinological Invest., July/August, 17(7), pp. 565-72.

305) Miyazaki, et al. "T Cell Activation and Anergy to Islet Cell Antigen in Type-I Diabetes." J. Immunol., February, 1995, 154(3), pp. 1461-1469.

306) Cheung, et. al. "T Cells From Children With IDDM are Sensitized to Bovine Serum Albumin." J. Immunol., December, 1994, 40(6), pp. 623-628.

307) Breslau. "Calcium, Estrogen and Progestin in the Treatment of Osteoporosis," Rheum-Dis-Clin-North-Am., August, 1994, 20(3), pp. 691-716.

308) Holick. "Environmental Factors that Influence the Cutaneous Production of Vitamin D." Am-J-Clin-Nutr., March, 1995, 61(3 Suppl). pp. 638S-645S.

309) Schacht. "Differential Therapy of Osteoporosis--An Overview Based on Recent Findings Regarding the Pathogenesis." Z-Rheumatol., September/October, 1994, 3(5), pp. 274-298.

310) Nelson, et al. "Effects of High-Intensity Strength Training on Multiple Risk Factors for Osteoporotic Fractures. A Randomized Controlled Trial." JAMA, December 28, 1994, 272(24), pp. 1909-1914.

311) Ortego, et al. "Bone Mineral Density, Sex Steroids, and Mineral Metabolism in Premenopausal Smokers." Calcif-Tissue-Int., December, 1994, 55(6), pp. 403- 407.

312) Sarli, et al. "Alcoholic Osteopathy." Medicina-B-Aires, 1994; 54(4), pp.363-370.

313) Harris H. McIlwain, M.D., and Debra Fulghum Bruce. Stop Osteoarthritis Now! New York: Simon & Schuster, 1996, p. 176.

314) Siegfried Kra, M.D. What Every Woman Must Know About Heart Disease. New York: Warner Books, 1996.

315) Heaney and McDowell. "Calcium in Milk vs. Calcium in Bottled Water." University of Omaha Study, November, 1994.

316) U.S. News and World Report. January 12, 1997, p. 22.

317) Phone conversation with Alexandra Gorman, January 15, 1997.

318) Food Microbiology,1990, 7, pp. 253-279.

319) British Food Journal, 1992, 94 (9), pp. 23-26.

320) Steve Sternberg. Science News, vol. 150, October 12, 1996.

321) John Stauber and Sheldon Rampton. "Toxic Sludge is Good For You."

Email: 74250.735@ compuserve.com

322) Virgil Hulse. Mad Cows and Milk Gate. Phoenix, Oregon: Marble Mountain Publishing, 1996.

323) Chicago Life, July/August, 1996.

324) Journal of Neurology, January, 1989.

325) Mad Cows and Milk Gate, ibid., p. 67.

326) John Collinge, et al. "Molecular analyses of prion Stran variation and the aetiology of'new variant' CJD." Nature, vol. 24, October, 1996, p. 685

327) S. B. Prusiner. "Molecular biology of Prion diseases." Science, vol. 252, June 14, 1991, pp. 1515-1522,

328) Stanley Prusiner. "Prion Diseases." Scientific American, January, 1995, pp. 48-57.

329) John Darnton. "Britain Ties Deadly Brain Disease to Cow Ailment." The New York Times, vol. CXLV, no. 50,373, March 21, 1996, p. 1 & A7.

330) Virgil Hulse. Mad Cows and Milk Gate. Phoenix, Oregon: Marble Mountain Publishing, 1996.

331) Howard Lyman, transcript of speech given at the World Vegetarian Congress in the Hague, Netherlands, August, 1994.

332) Evan Halper. "Food Fight." In These Times, Chicago, Il., 8/11/97, pp. 24-25.

333) Michael Hornsby. "New CJD Strain Threatens Thousands." London Times, August 23, 1997.

334) Richard Rhodes. Deadly Feasts. New York: Simon & Schuster, 1997.

335) Letter from Dr. Carleton Gajdusek to Robert Cohen, May 4, 1997.

336) Handbook of the Nutritional Content of Foods, Prepared for the USDA, New York: Dover Publications Inc., 1975.